U.S. FDA Issues Complete Response Letter for Baricitinib
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
Incyte (INCY) PT Lowered to $148 at Jefferies Following CRL
April 17, 2017 6:44 AM UTCJefferies lowered its price target on Incyte (NASDAQ: INCY) to $148.00 (from $165.00) while maintaining a Buy rating after the "surprising" CRL on Olumiant.
Analyst Brian Abrahams said while there could be many possibilities for the FDA issue their best guess is... More
